374 related articles for article (PubMed ID: 28520213)
1. The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
BasuRay S; Smagris E; Cohen JC; Hobbs HH
Hepatology; 2017 Oct; 66(4):1111-1124. PubMed ID: 28520213
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.
BasuRay S; Wang Y; Smagris E; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9521-9526. PubMed ID: 31019090
[TBL] [Abstract][Full Text] [Related]
3. Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.
Mitsche MA; Hobbs HH; Cohen JC
J Biol Chem; 2018 May; 293(18):6958-6968. PubMed ID: 29555681
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
Wang Y; Kory N; BasuRay S; Cohen JC; Hobbs HH
Hepatology; 2019 Jun; 69(6):2427-2441. PubMed ID: 30802989
[TBL] [Abstract][Full Text] [Related]
5. Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
Su H; Haque M; Becker S; Edlund K; Duda J; Wang Q; Reißing J; Marschall HU; Candels LS; Mohamed M; Sjöland W; Liao L; Drexler SA; Strowig T; Rahnenführer J; Hengstler JG; Hatting M; Trautwein C
Liver Int; 2023 Aug; 43(8):1699-1713. PubMed ID: 37073116
[TBL] [Abstract][Full Text] [Related]
6. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH
Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523
[TBL] [Abstract][Full Text] [Related]
7. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
[TBL] [Abstract][Full Text] [Related]
8. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
Li JZ; Huang Y; Karaman R; Ivanova PT; Brown HA; Roddy T; Castro-Perez J; Cohen JC; Hobbs HH
J Clin Invest; 2012 Nov; 122(11):4130-44. PubMed ID: 23023705
[TBL] [Abstract][Full Text] [Related]
9. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Lindén D; Ahnmark A; Pingitore P; Ciociola E; Ahlstedt I; Andréasson AC; Sasidharan K; Madeyski-Bengtson K; Zurek M; Mancina RM; Lindblom A; Bjursell M; Böttcher G; Ståhlman M; Bohlooly-Y M; Haynes WG; Carlsson B; Graham M; Lee R; Murray S; Valenti L; Bhanot S; Åkerblad P; Romeo S
Mol Metab; 2019 Apr; 22():49-61. PubMed ID: 30772256
[TBL] [Abstract][Full Text] [Related]
10. Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
Borén J; Adiels M; Björnson E; Matikainen N; Söderlund S; Rämö J; Henricsson M; Ripatti P; Ripatti S; Palotie A; Mancina RM; Ainola M; Hakkarainen A; Romeo S; Packard CJ; Taskinen MR
J Intern Med; 2022 Feb; 291(2):218-223. PubMed ID: 34411351
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin E3 ligase BFAR promotes degradation of PNPLA3.
Das A; Cheng H; Wang Y; Kinch LN; Liang G; Hong S; Hobbs HH; Cohen JC
Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2312291121. PubMed ID: 38294943
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein.
Romeo S; Huang-Doran I; Baroni MG; Kotronen A
Curr Opin Lipidol; 2010 Jun; 21(3):247-52. PubMed ID: 20480550
[TBL] [Abstract][Full Text] [Related]
13. The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats.
Patsenker E; Thangapandi VR; Knittelfelder O; Palladini A; Hefti M; Beil-Wagner J; Rogler G; Buch T; Shevchenko A; Hampe J; Stickel F
J Nutr Biochem; 2022 Oct; 108():109081. PubMed ID: 35691594
[TBL] [Abstract][Full Text] [Related]
14. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
[TBL] [Abstract][Full Text] [Related]
15. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.
Chen W; Chang B; Li L; Chan L
Hepatology; 2010 Sep; 52(3):1134-42. PubMed ID: 20648554
[TBL] [Abstract][Full Text] [Related]
16. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
17. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
18. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.
He S; McPhaul C; Li JZ; Garuti R; Kinch L; Grishin NV; Cohen JC; Hobbs HH
J Biol Chem; 2010 Feb; 285(9):6706-15. PubMed ID: 20034933
[TBL] [Abstract][Full Text] [Related]
19. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
[TBL] [Abstract][Full Text] [Related]
20. Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
De Nicola S; Dongiovanni P; Aghemo A; Cheroni C; D'Ambrosio R; Pedrazzini M; Marabita F; Donnici L; Maggioni M; Fargion S; Colombo M; De Francesco R; Valenti L
PLoS One; 2014; 9(8):e106022. PubMed ID: 25171251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
